Abstract
Objective: Na+-K+-ATPase (NKA) is essential in maintaining cell permeability, reserving potential energy, and preventing cellular edema. Nevertheless, how NKA expression is altered and regulated in chronic rhinosinusitis with nasal polyps (CRSwNPs) remain uncertain. Therefore, the present study aimed to explore the expression and regulation of NKA in CRSwNP. Methods: NKA immunolabeling was assessed by the immunohistochemistry method, NKA protein levels were detected with the Western blotting method, and mRNA levels of NKA and aquaporin-5 (AQP5) were assayed by real-time PCR in nasal tissues from CRSwNP and control subjects. The co-localization of NKA with inflammatory cells was evaluated by immunofluorescence staining. In addition, human nasal epithelial cells (HNECs) were cultured and stimulated using various stimulators to evaluate the regulation of NKA. Results: We found significantly decreased NKA positive cells, NKA protein levels, and mRNA levels of NKA and AQP5 in nasal tissues from CRSwNP patients compared to control subjects, especially in eosinophilic CRSwNP. Furthermore, NKA mRNA levels in HNECs were downregulated by staphylococcal enterotoxin B (SEB), lipopolysaccharides (LPSs), inflammatory cytokine (IFN)-γ, IL-4, IL-13, and IL-1β. Conclusion: NKA and AQP5 expressions were decreased in CRSwNP. NKA in HNECs could be suppressed by SEB, LPS, IFN-γ, IL-4, IL-13, and IL-1β. Impairment of NKA may contribute to the genesis and development of CRSwNP via inducing AQP5 downregulation and edema.
References
1.
Phillips
KM
, Barbarite
E
, Hoehle
LP
, Caradonna
DS
, Gray
ST
, Sedaghat
AR
. Clinical traits characterizing an exacerbation-prone phenotype in chronic rhinosinusitis
. Otolaryngol Head Neck Surg
. 2019 Nov
;161
(5
):890
–6
. .2.
Huang
JC
, Chen
XH
, Wang
ZY
, Li
X
, Chang
LH
, Zhang
GH
. Interleukin-17A expression correlated with the prognosis of chronic rhinosinusitis with nasal polyps and the anti-interleukin-17A effect in a murine nasal polyps model
. ORL J Otorhinolaryngol Relat Spec
. 2020
;82
(5
):257
–67
. .3.
Damask
CC
, Ryan
MW
, Casale
TB
, Castro
M
, Franzese
CB
, Lee
SE
, Targeted molecular therapies in allergy and rhinology
. Otolaryngol Head Neck Surg
. 2021 Jan
;164
(Suppl 1
):S1
–S21
. .4.
Schleimer
RP
. Immunopathogenesis of chronic rhinosinusitis and nasal polyposis
. Annu Rev Pathol
. 2017 Jan 24
;12
:331
–57
. .5.
Lin
H
, Ba
G
, Tang
R
, Li
M
, Li
Z
, Li
D
, Increased expression of TXNIP facilitates oxidative stress in nasal epithelial cells of patients with chronic rhinosinusitis with nasal polyps
. Am J Rhinol Allergy
. 2020 Dec 29
:1945892420982411
. Epub ahead of print. .6.
Luo
X
, Li
C
, Wang
Y
, Yang
G
, Xu
Y
, Li
G
, Interleukin-33 promotes Th2/Th17 response in eosinophilic and non-eosinophilic nasal polyps
. ORL J Otorhinolaryngol Relat Spec
. 2020
;82
(1
):34
–9
. .7.
Gupta
SP
. Quantitative structure-activity relationship studies on Na+,K(+)-ATPase inhibitors
. Chem Rev
. 2012 Jun 13
;112
(6
):3171
–92
. .8.
Santander
VS
, Campetelli
AN
, Monesterolo
NE
, Rivelli
JF
, Nigra
AD
, Arce
CA
, Tubulin-Na(+), K (+) -ATPase interaction: involvement in enzymatic regulation and cellular function
. J Cell Physiol
. 2019 Jun
;234
(6
):7752
–63
.9.
Clausen
MV
, Hilbers
F
, Poulsen
H
. The structure and function of the Na,K-ATPase isoforms in health and disease
. Front Physiol
. 2017
;8
:371
. .10.
Kryvenko
V
, Wessendorf
M
, Morty
RE
, Herold
S
, Seeger
W
, Vagin
O
, Hypercapnia impairs Na,K-ATPase function by inducing endoplasmic reticulum retention of the β-subunit of the enzyme in alveolar epithelial cells
. Int J Mol Sci
. 2020 Feb 21
;21
(4
):21
. .11.
Goncalves-de-Albuquerque
CF
, Burth
P
, Silva
AR
, de Moraes
IM
, de Jesus Oliveira
FM
, Santelli
RE
, Oleic acid inhibits lung Na/K-ATPase in mice and induces injury with lipid body formation in leukocytes and eicosanoid production
. J Inflamm
. 2013 Oct 31
;10
(1
):34
.12.
Matthay
MA
. Resolution of pulmonary edema. Thirty years of progress
. Am J Respir Crit Care Med
. 2014 Jun 1
;189
(11
):1301
–8
. .13.
Chang
YL
, Jian
KR
, Lin
CS
, Wang
HW
, Liu
SC
. Dexamethasone attenuates methacholine-mediated aquaporin 5 downregulation in human nasal epithelial cells via suppression of NF-κB activation
. Int Forum Allergy Rhinol
. 2018 Jan
;8
(1
):64
–71
. .14.
Zhang
J
, Yan
M
, Gu
W
, Chen
A
, Liu
J
, Li
L
, Downregulation of Aquaporins (AQP1 and AQP5) and Na,K-ATPase in porcine reproductive and respiratory syndrome virus-infected pig lungs
. Inflammation
. 2018 Jun
;41
(3
):1104
–14
. .15.
Meltzer
EO
, Hamilos
DL
, Hadley
JA
, Lanza
DC
, Marple
BF
, Nicklas
RA
, Rhinosinusitis: establishing definitions for clinical research and patient care
. Otolaryngol Head Neck Surg
. 2004 Dec
;131
(6 Suppl l
):S1
–62
. .16.
Cao
PP
, Li
HB
, Wang
BF
, Wang
SB
, You
XJ
, Cui
YH
, Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese
. J Allergy Clin Immunol
. 2009 Sep
;124
(3
):478
–2
. .17.
Fokkens
WJ
, Lund
VJ
, Mullol
J
, Bachert
C
, Alobid
I
, Baroody
F
, EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists
. Rhinology
. 2012 Mar
;50
(1
):1
–12
. .18.
Tang
R
, Ba
G
, Li
M
, Li
Z
, Ye
H
, Lin
H
, Evidence for role of acid-sensing ion channel 1a in chronic rhinosinusitis with nasal polyps
. Eur Arch Otorhinolaryngol
. 2021 Jul
;278
(7
):2379
–86
.19.
Tang
R
, Li
ZP
, Li
MX
, Li
DW
, Ye
HB
, Su
KM
, Pro-inflammatory role of transient receptor potential canonical channel 6 in the pathogenesis of chronic rhinosinusitis with nasal polyps
. Int Forum Allergy Rhinol
. 2018 Nov
;8
(11
):1334
–41
. .20.
Wang
H
, Li
ZY
, Jiang
WX
, Liao
B
, Zhai
GT
, Wang
N
, The activation and function of IL-36γ in neutrophilic inflammation in chronic rhinosinusitis
. J Allergy Clin Immunol
. 2018 May
;141
(5
):1646
–58
. .21.
Seshadri
S
, Lu
X
, Purkey
MR
, Homma
T
, Choi
AW
, Carter
R
, Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis
. J Allergy Clin Immunol
. 2015 Dec
;136
(6
):1548
–58.e7
. .22.
Kuhar
HN
, Tajudeen
BA
, Mahdavinia
M
, Gattuso
P
, Ghai
R
, Batra
PS
. Inflammatory infiltrate and mucosal remodeling in chronic rhinosinusitis with and without polyps: structured histopathologic analysis
. Int Forum Allergy Rhinol
. 2017 Jul
;7
(7
):679
–89
. .23.
Hamacher
J
, Hadizamani
Y
, Borgmann
M
, Mohaupt
M
, Männel
DN
, Moehrlen
U
, Cytokine-ion channel interactions in pulmonary inflammation
. Front Immunol
. 2017
;8
:1644
. .24.
Leite
JA
, Isaksen
TJ
, Heuck
A
, Scavone
C
, Lykke-Hartmann
K
. The alpha2 Na(+)/K(+)-ATPase isoform mediates LPS-induced neuroinflammation
. Sci Rep
. 2020 Aug 25
;10
(1
):14180
.25.
Wyse
AT
, Siebert
C
, Bobermin
LD
, Dos Santos
TM
, Quincozes-Santos
A
. Changes in inflammatory response, redox status and Na(+), K(+)-ATPase activity in primary astrocyte cultures from female wistar rats subject to ovariectomy
. Neurotox Res
. 2020 Feb
;37
(2
):445
–54
.26.
Perez-Bosque
A
, Amat
C
, Polo
J
, Campbell
JM
, Crenshaw
J
, Russell
L
, Spray-dried animal plasma prevents the effects of Staphylococcus aureus enterotoxin B on intestinal barrier function in weaned rats
. J Nutr
. 2006 Nov
;136
(11
):2838
–43
.27.
Lundborg
C
, Westerlund
A
, Björklund
U
, Biber
B
, Hansson
E
. Ifenprodil restores GDNF-evoked Ca(2+) signalling and Na(+)/K(+) -ATPase expression in inflammation-pretreated astrocytes
. J Neurochem
. 2011 Nov
;119
(4
):686
–96
. .28.
Bertelsen
LS
, Eckmann
L
, Barrett
KE
. Prolonged interferon-gamma exposure decreases ion transport, NKCC1, and Na+-K+-ATPase expression in human intestinal xenografts in vivo
. Am J Physiol Gastrointest Liver Physiol
. 2004 Jan
;286
(1
):G157
–65
. .29.
Kreydiyyeh
SI
, Abou-Chahine
C
, Hilal-Dandan
R
. Interleukin-1 beta inhibits Na+-K+ ATPase activity and protein expression in cardiac myocytes
. Cytokine
. 2004 Apr 7
;26
(1
):1
–8
. .30.
Kreydiyyeh
SI
, Riman
S
, Serhan
M
, Kassardjian
A
. TNF-alpha modulates hepatic Na+-K+ ATPase activity via PGE2 and EP2 receptors
. Prostaglandins Other Lipid Mediat
. 2007 Jun
;83
(4
):295
–303
. .31.
Bachert
C
, Holtappels
G
, Merabishvili
M
, Meyer
T
, Murr
A
, Zhang
N
, Staphylococcus aureus controls interleukin-5 release in upper airway inflammation
. J Proteomics
. 2018 May 30
;180
:53
–60
. .32.
Wang
SB
, Chen
SM
, Zhu
KS
, Zhou
B
, Chen
L
, Zou
XY
. Increased lipopolysaccharide content is positively correlated with glucocorticoid receptor-beta expression in chronic rhinosinusitis with nasal polyps
. Immun Inflamm Dis
. 2020 Dec
;8
(4
):605
–14
. .33.
Wee
JH
, Ko
YK
, Khalmuratova
R
, Shin
HW
, Kim
DW
, Rhee
CS
. Effect of lipopolysaccharide and polyinosinic:polycytidylic acid in a murine model of nasal polyp
. Sci Rep
. 2021 Jan 13
;11
(1
):1021
. .34.
Ismi
O
, Ozcan
C
, Polat
G
, Kul
S
, Gorur
K
, Puturgeli
T
. TNF-alpha and IL-1 beta cytokine gene polymorphism in patients with nasal polyposis
. Turk Arch Otorhinolaryngol
. 2017 Jun
;55
(2
):51
–6
.35.
Han
X
, Wu
D
, Sun
Z
, Sun
H
, Lv
Q
, Zhang
L
, Type 1/type 2 inflammatory cytokines correlate with olfactory function in patients with chronic rhinosinusitis
. Am J Otolaryngol
. 2020 Sep– Oct
;41
(5
):102587
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
